Michael Paley

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Uveitis 63%
3. tofacitinib 44%
4. Chronic Disease 43%
5. Central Tolerance 43%
6. Programmed Cell Death 1 Receptor 43%
7. Vaccination 39%
8. Innate Immunity 39%
9. Peripheral Tolerance 39%
10. Eye Diseases 35%
11. SARS Virus 34%
12. Virus Diseases 34%
13. Adaptive Immunity 32%
14. Viremia 32%
15. T-box transcription factor TBX21 29%
16. Infections 29%
17. Antiviral Agents 28%
18. Cytomegalovirus 28%
19. Eye 27%
20. B-Lymphocytes 26%
21. Vaccines 25%
22. HLA-A29 antigen 25%
23. Messenger RNA 24%
24. Birdshot Chorioretinopathy 24%
25. Viruses 24%
26. Transcription Factors 24%
27. Arthropod Proteins 23%
28. Antibodies 22%
29. Immunity 22%
30. Neurosarcoidosis 22%
31. Antigens 20%
32. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 20%
33. Scleritis 20%
34. Salivary Proteins and Peptides 20%
35. T-Lymphoid Precursor Cells 20%
36. HLA-A Antigens 20%
37. Hepatitis Delta Virus 19%
38. Vaccine Immunogenicity 19%
39. T Cell Transcription Factor 1 19%
40. Tumor Necrosis Factor Inhibitors 19%
41. Hydralazine 18%
42. Autoimmunity 18%
43. Bullous Pemphigoid 18%
44. Severe Acute Respiratory Syndrome 18%
45. T-Cell Antigen Receptor 18%
46. Coronavirus 17%
47. Genes 16%
48. Peptides 16%
49. Th1 Cells 16%
50. Immunosuppression 16%